Abstract

You have accessJournal of UrologyStone Disease: Medical & Dietary Therapy1 Apr 2017MP90-09 THE METABOLIC SYNDROME AND ITS IMPACT ON CALCIUM OXALATE STONE TYPE Egor Parkhomenko, Kathleen Kan, Timothy Tran, Julie Thai, Kyle Blum, and Mantu Gupta Egor ParkhomenkoEgor Parkhomenko More articles by this author , Kathleen KanKathleen Kan More articles by this author , Timothy TranTimothy Tran More articles by this author , Julie ThaiJulie Thai More articles by this author , Kyle BlumKyle Blum More articles by this author , and Mantu GuptaMantu Gupta More articles by this author View All Author Informationhttps://doi.org/10.1016/j.juro.2017.02.2828AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookTwitterLinked InEmail INTRODUCTION AND OBJECTIVES The metabolic syndrome plays an important role in lithogenesis of calcium oxalate stones, but to our knowledge no study has clinically correlated metabolic factors that influence stone subtype. It has been indicated that calcium oxalate monohydrate (COM) stones are more likely of tubular origin as secondary deposits onto calcium apatite whereas calcium oxalate dihydrate (COD) stones are more likely to form in solution. We sought to perform a comprehensive analysis of metabolic and clinical factors in patients who make predominantly one type of calcium oxalate stone. METHODS From our prospectively maintained database of 1049 kidney stone formers between 01/2014 - 06/2016, we identified 95 patients with comprehensive medical records including stone analysis who had predominantly (≥80%) COM (75 pts) or COD (20 pts) composition. Another 27 patients had mixed COM and COD stones (<80% of one subtype). Clinical, demographic and laboratory parameters were compared between (>80%) COM or COD stones. RESULTS There were no differences in age, gender or BMI between the COM and COD patients. COM patients were more likely to be hypertensive (46.7% vs. 15% p=0.01) and this difference was more pronounced in males (60% vs. 16.7%, p=0.007). Male COM patients were also more likely to be diabetic (22% vs. 0%, p=0.102). There were no differences in hyperlipidemia, coronary artery disease, gastrointestinal disease, and serum markers of uric acid, calcium, creatinine or HbA1c. COM patients were more likely to have hypocitraturia compared to COD patients (49.3% vs. 25%, p = 0.05). Male COM patients had significantly higher urinary oxalate levels (48 vs. 37 mg/d, p=0.05) compared to male COD formers. COD females showed a trend towards higher calcium levels vs. COM females (213 vs. 140 mg/d, p=0.13). The calcium/oxalate ratio in COD formers was significantly higher compared to COM formers (6.46 vs. 4.84, p < 0.05). No differences were observed for urine uric acid levels, supersaturation of uric acid, CaOx supersaturation, magnesium, and pH. CONCLUSIONS Our study suggests that HTN and DM, two components of the metabolic syndrome, are more closely linked to COM stones compared to COD stones. Patients with higher urine oxalate and lower urine citrate levels tend to form COM stones, while those with a higher urine calcium/oxalate ratio tend to form COD stones. This suggests that the two stone subtypes are clinically and metabolically different and thus may have different etiology. © 2017FiguresReferencesRelatedDetails Volume 197Issue 4SApril 2017Page: e1213 Advertisement Copyright & Permissions© 2017MetricsAuthor Information Egor Parkhomenko More articles by this author Kathleen Kan More articles by this author Timothy Tran More articles by this author Julie Thai More articles by this author Kyle Blum More articles by this author Mantu Gupta More articles by this author Expand All Advertisement Advertisement PDF downloadLoading ...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call